Fritextsökning
Innehållstyper
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
"Imponerande kraftsamling gav vaccin"
Det rekordsnabba framtagandet av nya vaccin under pandemin visar vad läkemedelsindustrin – och mänskligheten – kan åstadkomma när pressen är tillräckligt stor.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Avtalet med Almirall sägs upp
Index får tillbaka de europeiska rättigheterna för läkemedelskandidaten Kappaproct mot ulcerös kolit.
-
Relax at the After Fair
Round off the first day of the fair by visiting the After Fair. You can reload with entertainment from talented artists such as Patrik Isaksson, The Gentlemen a...
-
Studie: Enkel dos antibiotika kan förhindra var tredje fall av sepsis vid förlossning
En enda dos antibiotika minskar kraftigt risken för sepsis under förlossning och kan därmed rädda miljontals kvinnor i låg- och medelinkomstländer från att drab...
-
Ny metod förutser lovande läkemedel
Enligt en ny studie kan forskningsbolaget Attanas teknik förbättra lyckandegraden för kliniska studier.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Astra Zeneca nådde inte mål i lungcancerstudie
-
Storbritannien har godkänt injektion för viktminskning
Storbritannien börjar med läkemedel för viktminskning för personer med kraftig fetma. Hälsomyndigheten har godkänt läkemedlet Ozempic (semaglutide) från danska ...
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.